Kangyun Interconnect Launches World's First 'Internet + IVD' Medical Testing System, Ushering in the Era of Self-Testing

VCBeat (WeChat ID: vcbeat) has learned that Kangyun Interconnect, a company focused on the development of intelligent IVD diagnostic platforms, recently announced that its developed“"Cloud-based Intelligent Detection System (CONIN)"Having passed the review by the National Medical Products Administration (NMPA), the medical device registration certificate has been officially obtained. This means that multiple medical testing services provided by Kangyun Hulian can now be used in mainland China, following their market launch in the European Union.

According to publicly available information,This system is the only “Internet + IVD” medical testing solution currently on the market that enables personal-to-cloud connectivity and holds qualifications for remote assisted diagnosis, marking a global first!

Meanwhile,Kangyun Interconnect is also the only company in the industry with compliance qualifications., it has secured over 100 intellectual property rights, including dozens of patents (of which 12 are invention patents), covering core areas such as detection systems, detection methods, and sensors, thereby maintaining an industry-leading position in both quantity and quality.

Kangyun Interconnect was established in March 2016, dedicated to the research, development, and production of foundational technologies for “Internet + IVD” (In Vitro Diagnostics) and supporting medical products. The company has consistently taken it as its mission to comprehensively reduce the cost of medical testing, providing users with “Internet+” solutions for convenient and efficient health screening, chronic disease management, remote assisted diagnosis, and smart healthcare.

The CONIN Cloud Testing System, recently approved, represents Kangyun Interconnect’s breakthrough endeavor in the “Internet + IVD” sector, disrupting the traditional IVD industry.Pioneered the niche market of internet-based in vitro diagnostics, making home self-testing a reality。

Unlike traditional in vitro diagnostics, Kangyun Hulian enables medical-grade testing with just a smartphone and a test kit—no hardware instruments required!

Operating Procedures

Users simply need to immerse the test reagent into the sample or apply the sample onto the reagent. After allowing the reaction to proceed as instructed, they can take a photo with their mobile phone and scan the QR code to upload the image to the cloud-based testing system. Precise test results will be delivered within five seconds. This truly enables on-the-go health screenings, with reports generated in just seconds!

Kangyun Interconnect is now capable of performing 80% of testing items, including vital signs monitoring, routine urinalysis, biochemical assays, immunoassays, specific protein analysis, and molecular diagnostics. It meets the majority of in vitro diagnostic (IVD) testing needs, with all results fully compliant with medical standards.

What is the motivation behind developing such a CONIN detection system based on a pure internet architecture?

Wu Fan, founder and chairman of Kangyun Hulian, told VCBeat that medical resources in China are scarce and unevenly distributed, with high-quality resources largely concentrated in tertiary hospitals in major cities. How to channel more medical resources down to the grassroots level, bringing them closer to ordinary sub-healthy individuals and patients, has become a concern for society as a whole.

The emergence of internet healthcare has broken this deadlock, fulfilling multiple demands such as online consultations, appointment scheduling, medication counseling, and health management.

However, the seemingly perfect closed-loop internet healthcare system has a significant gap: the lack of timely remote diagnostic evidence.Based solely on the patient’s description, it is difficult for physicians to make an accurate diagnosis; therefore, in most cases, patients are required to undergo hospital-based examinations, resulting in substantial time costs.

“It can be said that the development of the entire internet healthcare industry has been stalled at the critical link of diagnostic testing.“Wu Fan said.”

The primary reason is that most current health examinations rely on large-scale diagnostic equipment, necessitating patients to visit hospitals or medical examination centers for testing.

In recent years, with the advancement of device miniaturization, patients have been able to conduct examinations at home using handheld devices. However, issues such as poor interoperability and high costs persist. Although compact devices have made certain inroads in the niche market of chronic disease management, they have yet to penetrate the broader and more substantial general health management market.

The CONIN system developed by Kangyun Interconnect pushes device miniaturization to its ultimate limit—virtualization., by leveraging diverse interdisciplinary theories and technologies such as nanotechnology, new materials, molecular structures, and chemistry, traditional detection techniques are innovated to achieve non-destructive amplification of reaction signals and markers (Nano-S). Optical information is then captured via smartphone cameras, and cloud technology combined with a comprehensive suite of reproducible complex algorithms (OPLA) is employed to ultimately generate highly reliable test results in the cloud.

This not only disrupts the existing IVD industry from the perspectives of hardware and cost, but also reveals the advent of the “self-testing era” across temporal and spatial dimensions.

In Wu Fan’s view, the miniaturization of IVD (in vitro diagnostic) equipment is currently the dominant trend, while device virtualization and cloud-based functionality represent an inevitable direction for technological advancement. The CONIN system functions as a cloud-based testing platform, with the marginal cost of its functional implementation approaching zero.

Moreover, with the widespread adoption of the internet and smartphones, such purely internet-based testing methods will become universally accessible, easy to use for everyone.

“I believe that with the rise of internet healthcare technologies and the liberalization of related policies, mobile remote health screening (testing) is highly likely to become the mainstream in the IVD industry, replacing most functions and use cases of traditional medical testing, thereby paving a broad path for medical services such as human health management, disease screening, chronic disease management, and remote diagnosis.”Wu Fan stated.

Emerging innovations invariably encounter unforeseen challenges when brought to market. It is difficult for Kangyun Interconnect, acting alone, to rapidly shift public mindsets away from traditional paradigms and foster acceptance of this novel internet-based medical testing approach; concerted efforts across the entire industry chain are required.

Therefore,Kangyun Interconnect plans to transform this cloud-based testing system into an open platform, making its standards and authorizations publicly available so that all upstream and downstream institutions and enterprises can integrate with it.

Kangyun Interconnect aims to provide value-added services to upstream and downstream enterprises through this open platform, empowering the entire industry chain to drive forward development. It is reported that all basic services will be offered free of charge during the early promotional phase.

So, what are the benefits for upstream and downstream enterprises to access the Kangyun Interconnect Platform? Wu Fan told VCBeat that there are mainly the following aspects.

For upstream IVD manufacturers,, adapting and upgrading traditional test strips into smart test strips, with production processes and workflows largely consistent with those of conventional instruments.However, with costs remaining unchanged, the increase in product added value will lead to a substantial rise in profit margins.

Looking at the domestic IVD industry as a whole, it is currently experiencing a minor surge, with fierce competition and a market that has long become a red ocean. If companies are willing to integrate with cloud-based testing platforms and leverage the tailwinds of “Internet+,” they can seize this wave of online dividends, reach more users, and expand their sales channels.

Meanwhile,This also represents a significant benefit to downstream entities, including internet healthcare platforms, insurance companies, big data firms, pharmacies, clinics, and nursing homes.

First,For internet healthcare companies, Kangyun Hulian addresses the critical pain point of lacking diagnostic evidence. With comprehensive laboratory test reports, even online consultations can achieve diagnostic accuracy comparable to that of in-person, face-to-face evaluations by physicians.

Second,For insurance companies, acquiring user health data at low cost enables them to provide health alerts and management services to their customers, thereby reducing claim ratios. Meanwhile, they can also leverage this platform for promotional activities and other initiatives.

Third,For traditional hospitals, after integrating with the Kangyun Interconnected Platform, their official WeChat accounts can not only publish various medical information but also offer in vitro diagnostic testing services, thereby achieving online-offline integration.

The method for integrating with the platform is also very simple. Enterprises only need to install the system installation package provided by Kangyun Interconnect, after which their apps, WeChat Official Accounts (both Service Accounts and Subscription Accounts are acceptable), websites, and other platforms will seamlessly connect with Kangyun Interconnect’s servers to access the corresponding services. The installed software ensures that platforms such as WeChat Official Accounts and apps operate with high stability, delivering a user experience virtually indistinguishable from that of Kangyun Interconnect’s native platform.

Therefore, empowered by the Kangyun Interconnected Cloud Platform, many previously irreplaceable offline methods can now be substituted, representing a significant dividend for the entire industry.

“In fact, developing such a platform involves extremely high barriers to entry and stringent regulatory oversight. We devoted considerable time and substantial capital investment to achieve a highly mature technological foundation. As pioneers in the ‘Internet + IVD’ sector, we are committed to sharing our advancements to prevent unnecessary redundant development,” stated Wu Fan. “We also aspire to collaborate with more partners to leverage the Kangyun Interconnect platform in promoting the healthy development of the industry and enhancing the nation’s overall health standards.”

It is reported that the company is currently preparing for a new round of financing, aiming to leverage capital to rapidly achieve commercial implementation. We also look forward to seeing Kangyun Interconnect’s products hit the market soon.